Literature DB >> 32591093

Dermatomyositis Developed After Exposure to Epstein-Barr Virus Infection and Antibiotics Use.

Rahul Peravali1, Saurav Acharya2, Syed Hasan Raza3, Debendra Pattanaik3, Milton Barry Randall4.   

Abstract

Dermatomyositis is an inflammatory disorder involving muscle and skin. Similar to many other autoimmune diseases, environmental factors appear to trigger the onset of disease in some cases. Many drugs have been reported to be associated with dermatomyositis, and rarely infections have been described as potential triggering agents. Here we are describing a case of dermatomyositis that developed after doxycycline and levofloxacin use, who also had recent Epstein-Barr virus infection. Dermatomyositis associated with doxycycline or levofloxacin use has not yet been described in the literature, while reports of dermatomyositis after Epstein-Barr virus infection have been rare and limited to juvenile dermatomyositis or in association with cancer. It is important for clinicians to be aware of this rare association so that the diagnosis and treatment can be exercised promptly.
Copyright © 2020 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibiotics associated dermatomyositis; Dermatomyositis; EBV associated dermatomyositis

Mesh:

Substances:

Year:  2020        PMID: 32591093      PMCID: PMC7687046          DOI: 10.1016/j.amjms.2020.05.011

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  17 in total

Review 1.  Mechanisms of action of antimicrobials: focus on fluoroquinolones.

Authors:  D C Hooper
Journal:  Clin Infect Dis       Date:  2001-03-15       Impact factor: 9.079

2.  Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.

Authors:  Keiji Iwatsuki; Masataka Satoh; Takenobu Yamamoto; Takashi Oono; Shin Morizane; Mikio Ohtsuka; Zi-Gang Xu; Daisuke Suzuki; Kazuhide Tsuji
Journal:  Arch Dermatol       Date:  2006-05

Review 3.  Musculoskeletal complications of fluoroquinolones: guidelines and precautions for usage in the athletic population.

Authors:  Mederic M Hall; Jonathan T Finnoff; Jay Smith
Journal:  PM R       Date:  2011-02       Impact factor: 2.298

4.  Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury.

Authors:  Michelle P Bendeck; Michelle Conte; Mingyu Zhang; Nafiseh Nili; Bradley H Strauss; Stephanie M Farwell
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

Review 5.  Dermatomyositis induced by drug therapy: a review of case reports.

Authors:  Anne M Seidler; Alice B Gottlieb
Journal:  J Am Acad Dermatol       Date:  2008-07-14       Impact factor: 11.527

6.  Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy.

Authors:  Mahasweta Girgenrath; Mary Lou Beermann; Vivek K Vishnudas; Sachiko Homma; Jeffrey Boone Miller
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

Review 7.  A Potential Link between Environmental Triggers and Autoimmunity.

Authors:  Aristo Vojdani
Journal:  Autoimmune Dis       Date:  2014-02-12

8.  Genetic association study of TNFAIP3, IFIH1, IRF5 polymorphisms with polymyositis/dermatomyositis in Chinese Han population.

Authors:  Si Chen; Qian Wang; Ziyan Wu; Yuan Li; Ping Li; Fei Sun; Wenjie Zheng; Qingjun Wu; Chanyuan Wu; Chuiwen Deng; Fengchun Zhang; Yongzhe Li
Journal:  PLoS One       Date:  2014-10-22       Impact factor: 3.240

Review 9.  Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation.

Authors:  Andreas Lossius; Jorunn N Johansen; Øivind Torkildsen; Frode Vartdal; Trygve Holmøy
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

Review 10.  Anti-HMGCR Myopathy.

Authors:  Payam Mohassel; Andrew L Mammen
Journal:  J Neuromuscul Dis       Date:  2018
View more
  1 in total

1.  Polymyositis Presenting With Nontraumatic Rhabdomyolysis and Dysphagia: A Case Report.

Authors:  Jonathan Aldrete; Christopher J Peterson; James A Tarbox; John S Pixley
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.